SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-17-011327
Filing Date
2017-12-05
Accepted
2017-12-05 10:30:49
Documents
2
Period of Report
2017-11-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT a8-kqbioconversionagreeme.htm 8-K 27938
2 ADDITIONAL EXHIBITS qbiomedannouncesfullsettl.htm EX-99.1 8429
  Complete submission text file 0001654954-17-011327.txt   37690
Mailing Address 501 MADISON AVE. 14TH FLOOR NEW YORK NY 10022
Business Address 501 MADISON AVE. 14TH FLOOR NEW YORK NY 10022 212-588-0022
Q BioMed Inc. (Filer) CIK: 0001596062 (see all company filings)

IRS No.: 464013793 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 8-K | Act: 34 | File No.: 000-55535 | Film No.: 171238866
SIC: 2834 Pharmaceutical Preparations